309 related articles for article (PubMed ID: 2839663)
1. Endothelium-derived relaxing factor and nitric oxide possess identical pharmacologic properties as relaxants of bovine arterial and venous smooth muscle.
Ignarro LJ; Buga GM; Byrns RE; Wood KS; Chaudhuri G
J Pharmacol Exp Ther; 1988 Jul; 246(1):218-26. PubMed ID: 2839663
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological evidence that endothelium-derived relaxing factor is nitric oxide: use of pyrogallol and superoxide dismutase to study endothelium-dependent and nitric oxide-elicited vascular smooth muscle relaxation.
Ignarro LJ; Byrns RE; Buga GM; Wood KS; Chaudhuri G
J Pharmacol Exp Ther; 1988 Jan; 244(1):181-9. PubMed ID: 2826766
[TBL] [Abstract][Full Text] [Related]
3. Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of nitric oxide radical.
Ignarro LJ; Byrns RE; Buga GM; Wood KS
Circ Res; 1987 Dec; 61(6):866-79. PubMed ID: 2890446
[TBL] [Abstract][Full Text] [Related]
4. EDRF generation and release from perfused bovine pulmonary artery and vein.
Ignarro LJ; Buga GM; Chaudhuri G
Eur J Pharmacol; 1988 Apr; 149(1-2):79-88. PubMed ID: 3135198
[TBL] [Abstract][Full Text] [Related]
5. Activation of purified soluble guanylate cyclase by endothelium-derived relaxing factor from intrapulmonary artery and vein: stimulation by acetylcholine, bradykinin and arachidonic acid.
Ignarro LJ; Harbison RG; Wood KS; Kadowitz PJ
J Pharmacol Exp Ther; 1986 Jun; 237(3):893-900. PubMed ID: 2872327
[TBL] [Abstract][Full Text] [Related]
6. Acetylcholine stimulates release of endothelium-derived relaxing factor in coronary arteries of human organ donors.
Blaise GA; Stewart DJ; Guérard MJ
Can J Cardiol; 1993 Nov; 9(9):813-20. PubMed ID: 8281481
[TBL] [Abstract][Full Text] [Related]
7. Endothelium-derived relaxing factor is a selective relaxant of vascular smooth muscle.
Shikano K; Berkowitz BA
J Pharmacol Exp Ther; 1987 Oct; 243(1):55-60. PubMed ID: 3499504
[TBL] [Abstract][Full Text] [Related]
8. Association between cyclic GMP accumulation and acetylcholine-elicited relaxation of bovine intrapulmonary artery.
Ignarro LJ; Burke TM; Wood KS; Wolin MS; Kadowitz PJ
J Pharmacol Exp Ther; 1984 Mar; 228(3):682-90. PubMed ID: 6323677
[TBL] [Abstract][Full Text] [Related]
9. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide.
Ignarro LJ; Buga GM; Wood KS; Byrns RE; Chaudhuri G
Proc Natl Acad Sci U S A; 1987 Dec; 84(24):9265-9. PubMed ID: 2827174
[TBL] [Abstract][Full Text] [Related]
10. Endothelium-derived relaxing factor (EDRF) from cultured and fresh endothelial cells.
Gryglewski RJ; Trybulec M; Radziszewski W; Swierkosz T; Dudek R; Zembowicz A
Biomed Biochim Acta; 1988; 47(10-11):S61-6. PubMed ID: 2470361
[TBL] [Abstract][Full Text] [Related]
11. Relaxation of intrapulmonary artery and vein by nitrogen oxide-containing vasodilators and cyclic GMP.
Edwards JC; Ignarro LJ; Hyman AL; Kadowitz PJ
J Pharmacol Exp Ther; 1984 Jan; 228(1):33-42. PubMed ID: 6319670
[TBL] [Abstract][Full Text] [Related]
12. Endothelium-derived nitric oxide relaxes nonvascular smooth muscle.
Buga GM; Gold ME; Wood KS; Chaudhuri G; Ignarro LJ
Eur J Pharmacol; 1989 Feb; 161(1):61-72. PubMed ID: 2542037
[TBL] [Abstract][Full Text] [Related]
13. Superoxide dismutase does not improve penetration of endothelium-derived relaxing factor (EDRF) through the vessel wall.
Gräser T; Vedernikov YP
Biomed Biochim Acta; 1989; 48(4):351-3. PubMed ID: 2787633
[TBL] [Abstract][Full Text] [Related]
14. [Two types of relaxation responses mediated by cyclic GMP in cerebral arteries].
Kanamaru K; Waga S; Kojima T; Fujimoto K
No To Shinkei; 1989 Jun; 41(6):559-65. PubMed ID: 2553081
[TBL] [Abstract][Full Text] [Related]
15. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor.
Gryglewski RJ; Palmer RM; Moncada S
Nature; 1986 Apr 3-9; 320(6061):454-6. PubMed ID: 3007998
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneity of endothelium-dependent responses to acetylcholine in canine femoral arteries and veins. Separation of the role played by endothelial and smooth muscle cells.
Rubanyi GM; Vanhoutte PM
Blood Vessels; 1988; 25(2):75-81. PubMed ID: 3257889
[TBL] [Abstract][Full Text] [Related]
17. Abluminal release and asymmetrical response of the rabbit arterial wall to endothelium-derived relaxing factor.
Bassenge E; Busse R; Pohl U
Circ Res; 1987 Nov; 61(5 Pt 2):II68-73. PubMed ID: 3117407
[TBL] [Abstract][Full Text] [Related]
18. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor.
Palmer RM; Ferrige AG; Moncada S
Nature; 1987 Jun 11-17; 327(6122):524-6. PubMed ID: 3495737
[TBL] [Abstract][Full Text] [Related]
19. Inhibition by sulfhydryl compounds of vascular relaxation induced by nitric oxide and endothelium-derived relaxing factor.
Jia L; Furchgott RF
J Pharmacol Exp Ther; 1993 Oct; 267(1):371-8. PubMed ID: 8229764
[TBL] [Abstract][Full Text] [Related]
20. Differences in responsiveness of intrapulmonary artery and vein to arachidonic acid: mechanism of arterial relaxation involves cyclic guanosine 3':5'-monophosphate and cyclic adenosine 3':5'-monophosphate.
Ignarro LJ; Harbison RG; Wood KS; Wolin MS; McNamara DB; Hyman AL; Kadowitz PJ
J Pharmacol Exp Ther; 1985 Jun; 233(3):560-9. PubMed ID: 2989487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
